Biora Therapeutics Profit Margin

The latest profit margin for BIOR is -1787.93% as of September 2024. That compares with -704155.56% in the prior-year period — up 99.7% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside Biora Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, BIOR's profit margin moved from -704155.56% to -1787.93% — a 99.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biora Therapeutics's valuation or profitability profile.

Against Healthcare companies, BIOR currently prints -1787.93% for profit margin, while the sector average sits near 17.63%. That is roughly 10242.2% below the sector mean. Large gaps often invite a closer look at Biora Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Biora Therapeutics converts resources into returns. At -1787.93%, BIOR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -704155.56% in the prior-year period — up 99.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BIOR's profit margin (-1787.93%), review year-over-year change from -704155.56%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.